Grant: Alliance Grants
University of Ottawa
$50,000.00
Real-time Digital Quantification of SARS-CoV-2 viral RNA with Solid-State Nanopores for Rapid Detection of COVID-19 _x000d_ _x000d_ _x000d_ _x000d_ _x000d_ _x000d_ _x000d_ _x000d_
FY 2020-21
Summary
The urgency of the global health crisis caused by the novel corona virus SARS-CoV-2 calls for the development of rapid, low-cost, and accurate diagnostic tests. New technologies have emerged that can interrogate individual molecules to enable important new opportunities in healthcare, but to be effective tools for the fight against COVID-19 and future epidemics, they require the realization of two critical criteria. First, new tools will require ultrasensitivity, to enable detection of just a few copies of a pathogen in a sample. Second, since the benefit of early detection can be lost if the results are delayed and the opportunity to use those results for timely intervention is missed, these tools must also democratize detection, moving from centralized core labs to more rapid, low-cost testing on site.
Nanopore sensing is the most promising emerging ultrasensitive technology that is amenable to decentralization. Nanopores are inherently single molecule detectors and are entirely electrical in nature, with no need for complex and expensive optical components and dyes. They are uniquely suited to provide ultrasensitive detection in a miniaturized, portable, easy to use, and decentralized format.
In this proposal, we will establish proof of concept of solid-state nanopores as single-molecule electronic sensors for rapid and ultra-sensitive identification of SARS-CoV-2, compatible with an instrument platform the size of a smart phone, by demonstrating real-time counting of copies of the viral RNA generated from a customized amplification scheme. This project is uniquely positioned to advance the nanopore sensing field, and to strengthen the Canadian stake in this emerging area and in the larger diagnostics sector developing novel testing technologies for COVID-19. With this project, Canadians can look forward to better, faster, more precise, and more convenient molecular tests, especially in remote settings.
Program
Alliance Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
555057-2020
Name nom
Tabard-Cossa, Vincent
Department département
Physics
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3113
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biophysics
Research subject fr
Biophysique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Real-time Digital Quantification of SARS-CoV-2 viral RNA with Solid-State Nanopores for Rapid Detection of COVID-19 _x000d_
_x000d_
_x000d_
_x000d_
_x000d_
_x000d_
_x000d_
_x000d_
Keyword
NSERC
Application summary
The urgency of the global health crisis caused by the novel corona virus SARS-CoV-2 calls for the development of rapid, low-cost, and accurate diagnostic tests. New technologies have emerged that can interrogate individual molecules to enable important new opportunities in healthcare, but to be effective tools for the fight against COVID-19 and future epidemics, they require the realization of two critical criteria. First, new tools will require ultrasensitivity, to enable detection of just a few copies of a pathogen in a sample. Second, since the benefit of early detection can be lost if the results are delayed and the opportunity to use those results for timely intervention is missed, these tools must also democratize detection, moving from centralized core labs to more rapid, low-cost testing on site.
Nanopore sensing is the most promising emerging ultrasensitive technology that is amenable to decentralization. Nanopores are inherently single molecule detectors and are entirely electrical in nature, with no need for complex and expensive optical components and dyes. They are uniquely suited to provide ultrasensitive detection in a miniaturized, portable, easy to use, and decentralized format.
In this proposal, we will establish proof of concept of solid-state nanopores as single-molecule electronic sensors for rapid and ultra-sensitive identification of SARS-CoV-2, compatible with an instrument platform the size of a smart phone, by demonstrating real-time counting of copies of the viral RNA generated from a customized amplification scheme. This project is uniquely positioned to advance the nanopore sensing field, and to strengthen the Canadian stake in this emerging area and in the larger diagnostics sector developing novel testing technologies for COVID-19. With this project, Canadians can look forward to better, faster, more precise, and more convenient molecular tests, especially in remote settings.